Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group.
Tarlock K, Alonzo TA, Moraleda PP, Gerbing RB, Raimondi SC, Hirsch BA, Ravindranath Y, Lange B, Woods WG, Gamis AS, Meshinchi S. Tarlock K, et al. Among authors: woods wg. Br J Haematol. 2014 Jul;166(2):254-259. doi: 10.1111/bjh.12852. Epub 2014 Mar 25. Br J Haematol. 2014. PMID: 24661089 Free PMC article. Clinical Trial.
Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
Gamis AS, Woods WG, Alonzo TA, Buxton A, Lange B, Barnard DR, Gold S, Smith FO; Children's Cancer Group Study 2891. Gamis AS, et al. Among authors: woods wg. J Clin Oncol. 2003 Sep 15;21(18):3415-22. doi: 10.1200/JCO.2003.08.060. Epub 2003 Jul 28. J Clin Oncol. 2003. PMID: 12885836 Clinical Trial.
Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.
Barbaric D, Alonzo TA, Gerbing RB, Meshinchi S, Heerema NA, Barnard DR, Lange BJ, Woods WG, Arceci RJ, Smith FO. Barbaric D, et al. Among authors: woods wg. Blood. 2007 Mar 15;109(6):2314-21. doi: 10.1182/blood-2005-11-025536. Epub 2006 Dec 7. Blood. 2007. PMID: 17158236 Free PMC article.
Impact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: the Children's Oncology Group.
Horan JT, Alonzo TA, Lyman GH, Gerbing RB, Lange BJ, Ravindranath Y, Becton D, Smith FO, Woods WG; Children's Oncology Group. Horan JT, et al. Among authors: woods wg. J Clin Oncol. 2008 Dec 10;26(35):5797-801. doi: 10.1200/JCO.2007.13.5244. Epub 2008 Oct 27. J Clin Oncol. 2008. PMID: 18955460 Free PMC article.
FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group.
Kutny MA, Moser BK, Laumann K, Feusner JH, Gamis A, Gregory J, Larson RA, Powell BL, Stock W, Willman CL, Woods WG, Meshinchi S. Kutny MA, et al. Among authors: woods wg. Pediatr Blood Cancer. 2012 Oct;59(4):662-7. doi: 10.1002/pbc.24122. Epub 2012 Feb 29. Pediatr Blood Cancer. 2012. PMID: 22378655 Free PMC article.
234 results